Chiesi blocks Japanese drugmaker’s new brand at EU General Court
01-07-2020
EU adopts SPC manufacturing waiver
16-05-2019
Quinta / Shutterstock.com
The European Commission wants to increase access to generic medicines and crack down on anti-competitive behaviour in the pharmaceutical industry, a new plan has said.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
European Commission, generics, competition, Pharmaceutical Strategy for Europe, accessible, affordable, Ursula von der Leyen, Stella Kyriakides
